Shotaro Iwakiri

833 total citations
17 papers, 682 citations indexed

About

Shotaro Iwakiri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shotaro Iwakiri has authored 17 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Shotaro Iwakiri's work include Occupational and environmental lung diseases (5 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Shotaro Iwakiri is often cited by papers focused on Occupational and environmental lung diseases (5 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Shotaro Iwakiri collaborates with scholars based in Japan and China. Shotaro Iwakiri's co-authors include Makoto Sonobe, Ryo Miyahara, Hiroshi Date, K. Okubo, Nobuya Mino, Hiromi Wada, Shinjiro Nagai, Tsuyoshi Takahashi, Ei Nakayama and Toshi Menju and has published in prestigious journals such as Cancer, Cancer Research and American Journal Of Pathology.

In The Last Decade

Shotaro Iwakiri

15 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shotaro Iwakiri Japan 11 399 370 237 107 80 17 682
Anne‐Claire Voegeli France 15 355 0.9× 462 1.2× 305 1.3× 155 1.4× 40 0.5× 25 772
Alessandra Bulotta Italy 14 406 1.0× 249 0.7× 264 1.1× 124 1.2× 82 1.0× 47 695
Bernadette Reyna Asuncion United States 9 425 1.1× 301 0.8× 147 0.6× 98 0.9× 180 2.3× 16 658
Anna Wurtz United States 11 278 0.7× 296 0.8× 266 1.1× 127 1.2× 53 0.7× 19 595
Xinmin Zhao China 13 354 0.9× 259 0.7× 263 1.1× 138 1.3× 38 0.5× 47 666
Georgios Skliris Canada 8 475 1.2× 257 0.7× 419 1.8× 98 0.9× 147 1.8× 8 835
So‐Jung Choi South Korea 14 481 1.2× 416 1.1× 350 1.5× 222 2.1× 96 1.2× 25 875
Mariacarla Andreozzi Italy 10 607 1.5× 407 1.1× 177 0.7× 150 1.4× 176 2.2× 19 804
Hoa Q. Trummell United States 13 360 0.9× 176 0.5× 305 1.3× 94 0.9× 82 1.0× 19 620
Paris Vail United States 14 506 1.3× 239 0.6× 260 1.1× 203 1.9× 100 1.3× 15 739

Countries citing papers authored by Shotaro Iwakiri

Since Specialization
Citations

This map shows the geographic impact of Shotaro Iwakiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shotaro Iwakiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shotaro Iwakiri more than expected).

Fields of papers citing papers by Shotaro Iwakiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shotaro Iwakiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shotaro Iwakiri. The network helps show where Shotaro Iwakiri may publish in the future.

Co-authorship network of co-authors of Shotaro Iwakiri

This figure shows the co-authorship network connecting the top 25 collaborators of Shotaro Iwakiri. A scholar is included among the top collaborators of Shotaro Iwakiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shotaro Iwakiri. Shotaro Iwakiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Takeuchi, Shinji, Koji Fukuda, Tadaaki Yamada, et al.. (2017). Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation. Cancer Science. 108(4). 696–703. 12 indexed citations
2.
Yamada, Tadaaki, Joseph M. Amann, Koji Fukuda, et al.. (2015). Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma. Cancer Research. 75(19). 4188–4197. 17 indexed citations
4.
Li, Qi, Wei Wang, Tadaaki Yamada, et al.. (2014). Therapeutic activity of glycoengineered anti‐GM2 antibodies against malignant pleural mesothelioma. Cancer Science. 106(1). 102–107. 10 indexed citations
5.
Kobayashi, Masashi, Chenglong Huang, Makoto Sonobe, et al.. (2013). Snail Expression Is Associated With a Poor Prognosis in Malignant Pleural Mesotheliomas. The Annals of Thoracic Surgery. 95(4). 1181–1188. 14 indexed citations
6.
Kobayashi, Masashi, Cheng‐long Huang, Makoto Sonobe, et al.. (2012). Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients. Experimental and Therapeutic Medicine. 3(6). 952–958. 19 indexed citations
7.
Li, Qi, Wei Wang, Tadaaki Yamada, et al.. (2011). Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network. American Journal Of Pathology. 179(3). 1483–1493. 44 indexed citations
8.
Takahashi, Tsuyoshi, Makoto Sonobe, Toshi Menju, et al.. (2010). Mutations in Keap1 are a potential prognostic factor in resected non‐small cell lung cancer. Journal of Surgical Oncology. 101(6). 500–506. 63 indexed citations
9.
Iwakiri, Shotaro, Nobuya Mino, Tsuyoshi Takahashi, et al.. (2009). Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer. 115(11). 2580–2593. 85 indexed citations
10.
Takahashi, Tsuyoshi, Makoto Sonobe, Masashi Kobayashi, et al.. (2009). Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene. Annals of Surgical Oncology. 17(3). 889–897. 260 indexed citations
11.
Mino, Nobuya, Ryo Miyahara, Ei Nakayama, et al.. (2009). A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma. Journal of Surgical Oncology. 100(3). 267–272. 34 indexed citations
12.
Iwakiri, Shotaro, Shinjiro Nagai, Hiromichi Katakura, et al.. (2009). D2-40-Positive Lymphatic Vessel Density Is a Poor Prognostic Factor in Squamous Cell Carcinoma of the Lung. Annals of Surgical Oncology. 16(6). 1678–1685. 22 indexed citations
13.
Iwakiri, Shotaro, Makoto Sonobe, Shinjiro Nagai, et al.. (2008). Expression Status of Folate Receptor α Is Significantly Correlated with Prognosis in Non-Small-Cell Lung Cancers. Annals of Surgical Oncology. 15(3). 889–899. 96 indexed citations
14.
Yamada, Takashi, et al.. (2005). [Placement of an ultraflex nitinol stent for severe tracheobronchial obstruction in a case of relapsing polychondritis].. PubMed. 43(5). 328–32. 3 indexed citations
15.
Yamada, Tetsu, et al.. (2004). Two cases of spontaneous pneumothorax by ruptured paravertebral gourd-shaped bulla. The Journal of the Japanese Association for Chest Surgery. 18(6). 747–750.
16.
Teramoto, Koji, Toshihiko Satō, Shotaro Iwakiri, et al.. (2001). Clinical Study of 46 Cases of Surgically Resected Pulmonary Hamartomas.. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 62(4). 870–873. 2 indexed citations
17.
Ozaki, Yoshitomo, Masayoshi Kuwabara, Takafumi Matsui, et al.. (2000). A Case of Endobronchial Leiomyoma Resected by Transbronchial Endoscopic Electrosurgery. 22(5). 360–363.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026